This website uses cookies to ensure that we give you the best experience on our website. Click here for more information.


Terms of Use

The information contained in this site is for healthcare professionals only.

I am not a healthcare professional I confirm to be a healthcare professional

for her there is no such thing as a small fall 

Prolia® (denosumab) helps strengthen cortical AND TrABECULAR bone tissue and significantly reduce fracture risk

Learn more about Prolia®

About Prolia®

Prolia® (denosumab) is an antiresorptive medicine that is used to treat osteoporosis in postmenopausal women and in men at increased risk of osteoporotic fractures. 

learn more

Prolia® mechanism of action

Prolia® (denosumab) is a first in class therapy for bone loss with a mechanism of action that reduces the loss of bone and maintains bone strength, making fractures less likely to happen in post menopausal women.

learn more

Benefits of Prolia®

The efficacy of Prolia® (denosumab) has been demonstrated to improve bone density and strength and reduce the risk of osteoporotic fractures in both men and postmenopausal women at increased risk of fracture.

learn more

Prolia® Posology and Method of Administration

Prolia® (denosumab) is a 60 mg injection for osteoporosis administered subcutaneously every six months.

learn more

Prolia® Side Effects & Safety Information

Learn which denosumab side effects to look out for and safety precautions to take in patients with osteoporosis on treatment with Prolia® 

learn more

Find the information you need to prescribe Prolia® (denosumab) to your patients

Download relevant resources here.

Osteoporosis in women

Osteoporosis may occur in women after menopause. In postmenopausal women with osteoporosis Prolia® significantly reduces the risk of vertebral, non-vertebral and hip fractures.

learn more

Osteoporosis in men

Osteoporosis in men may be due to aging, low level of the male hormone, testosterone or hormone ablation therapy. In men with prostate cancer receiving hormone ablation, Prolia® (denosumab) significantly reduces the risk of vertebral fractures. 

learn more